GlassScriptPhysician profile
Anna Ester Garino
NPI 1063137362
$4,895.84
in general payments reported to CMS, 2019-2025
19 companies · $1,445 in 2025
The $1,445 reported for 2025 was more than what 92% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $826 · 2024: $2,625 · 2025: $1,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,580 · Travel and Lodging: $756 · Consulting Fee: $525 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,580.35 |
| Travel and Lodging | $756.49 |
| Consulting Fee | $525.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,882.10 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $365.25 | 2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $280.97 | 2023-2025 | Farxiga, Wainua, Lokelma |
| Alnylam Pharmaceuticals INC. | $224.82 | 2023-2025 | Onpattro, Amvuttra |
| Merck Sharp & Dohme LLC | $203.93 | 2023-2025 | Verquvo |
| Cvrx, INC. | $176.96 | 2025 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $171.83 | 2023-2025 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $152.05 | 2023-2025 | |
| Philips North America LLC | $72.25 | 2024-2025 | Mcot, (Ck4) Mcot |
| Lexicon Pharmaceuticals, INC. | $69.76 | 2023-2024 | Inpefa |
| Pfizer INC. | $68.50 | 2024-2025 | |
| Lilly USA, LLC | $41.54 | 2023-2025 | Mounjaro, Zepbound |
| Becton, Dickinson and Company | $34.00 | 2025 | Introducer Needle |
| Scpharmaceuticals INC. | $31.79 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.76 | 2023 | Jardiance |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.18 | 2024 | Lifevest |
| Daiichi Sankyo INC. | $23.36 | 2023 | Injectafer |
| Heartflow, INC. | $22.85 | 2025 | |
| Bridgebio Pharma, INC. | $20.94 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Garino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.